The first patients in southwest Missouri to receive the recently approved Alzheimer's disease medication Kisunla were treated at CMH last week. The Missouri Memory Center and CMH Research Department participated in the Trailblazer-ALZ 2 study that led to FDA approval of Kisunla (donanemab) on July 2. Kisunla is indicated for use in patients with mild cognitive impairment or mild dementia stages of Alzheimer’s disease.

CMH was the first health system in Missouri to add Kisunla to its formulary. Watch the KY3 News story or read the CMH news release.

CEO Update: An essential partnership for nursing education

Recruitment and retention of nurses is essential for the future growth of CMH. One of the things that we’re focused on is growing our relationships with our education partners. Read the blog post or watch the video to learn more about the ways we partner with Bolivar Technical College for nursing education.

Welcome Dr. Russell Davis to the CMH Nephrology Clinic

Russell “Rusty” Davis III, D.O., nephrologist, is now seeing patients at the new CMH Nephrology Clinic. He is board certified by the American Board of Internal Medicine and specializes in diagnosing and treating a variety of kidney conditions. Call the CMH Nephrology Clinic at 417-328-7300 for more information.

Bid online in the Soirée silent auction through Sept. 28

We hope to see you at the Soirée, but if you can't be there, you can still bid on silent auction items online. Auction proceeds benefit the CMH Birth Place, area newborns and their families. Bid on silent auction items by creating an account. The auction closes at 7 p.m. Saturday, Sept. 28. You can pay online for items you win.

CMH Health News is an e-newsletter published by Citizens Memorial Hospital and Citizens Memorial Health Care Foundation twice a month. For more information, email marketing@citizensmemorial.com.